This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Bromelin, a Compound Prepared With Ananas Comocus Extract and Honey, for Acute Cough (BROMETOSS)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Universidade Federal de Pernambuco.
Recruitment status was:  Recruiting
Information provided by:
Universidade Federal de Pernambuco Identifier:
First received: May 12, 2011
Last updated: June 27, 2011
Last verified: March 2011

Cough is the most bothersome symptom for patients with the common cold.

The objective of the study is to compare the phytotherapic "Bromelin", a compound preparation of honey from the bee apis mellifera with the extract of the pineapple (Ananas comosus) with placebo in reducing cough episodes in patients with the common cold.

Condition Intervention Phase
Cough, Acute Drug: Bromelin Drug: Placebo Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Randomized,Double-blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of the Phytotherapic Compound "Bromelin" on Acute Irritative Cough

Resource links provided by NLM:

Further study details as provided by Universidade Federal de Pernambuco:

Primary Outcome Measures:
  • Change in score in a cough evaluation questionnaire [ Time Frame: before and 10 and 30 minutes after the dosing ]
    A cough score based on number of coughing episodes and subjective 5 item cough score : no cough, mild, moderate, severe, very severe.

Secondary Outcome Measures:
  • Change in Occurrence of gastric symptoms [ Time Frame: 10 and 30 minutes ]
    Question "YES" as answer to questions about gastric symptoms as nausea and/or vomiting after medication

Estimated Enrollment: 102
Study Start Date: June 2011
Estimated Study Completion Date: March 2012
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Active drug
Bromelin. Extract from Ananas comosus, 3,3g on vehicle (methylparaben, propylparaben, honey from apis mellifera, sodium benzoate, ethylic alcohol, water) 5ml.
Drug: Bromelin
Ananas comosus extract (3,3g) on vehicle: methylparaben, propylparaben, honey from Apis mellifera, sodium benzoate, ethilic alcohol, water) 5ml. Given in single dose.
Other Names:
  • Bromelein
  • Ananas comosus extract
Placebo Comparator: Placebo
Placebo comparator with the same characteristics of experimental drug, 5ml, single dose.
Drug: Placebo
Placebo with mimicking characteristics of experimental drug

Detailed Description:

Common cold is very frequent and cough is one of the most troublesome symptoms. Over-the-counter medications are used by patients without prescription, many times with important side effects.

Bromelin, a compound made with honey and pineapple extract could offer cough symptomatic relief as a soothing agent.

This study aims to compare this compound with placebo in reducing cough in patients with common cold in an clinical trial designed in conformity to CONSORT guidelines.


Ages Eligible for Study:   2 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • cough for less than 24 hours
  • common cold symptoms : nasal obstruction, headache, myalgias, runny nose.

Exclusion Criteria:

  • declared chronic pulmonary diseases declared Nervous diseases declared Diabetes declared cardiac diseases known primary or secondary immunodeficiencies
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01356693

Contact: Emanuel SC Sarinho, MD, PhD 55-81-88814801

Hospital das Clínicas/UFPE Recruiting
Recife, PE, Brazil, 50670-901
Contact: Emanuel S Sarinho, MD, PhD    55-81-88814801   
Contact: Decio M Peixoto, MD, PhD    55-81-86636709   
Sub-Investigator: Jose A Rizzo, MD, PhD         
Sub-Investigator: Dinaldo C Oliveira, MD, PhD         
Sub-Investigator: Almerinda R silva, MD, MsC         
Sponsors and Collaborators
Universidade Federal de Pernambuco
Study Director: Decio M Peixoto, MD, PhD UFPE
Principal Investigator: Emanuel SC Sarinho, MD, PhD UFPE
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Emanuel Sávio Cavalcanti Sarinho, Universidade Federal de Pernambuco Identifier: NCT01356693     History of Changes
Other Study ID Numbers: Brom1
Study First Received: May 12, 2011
Last Updated: June 27, 2011

Keywords provided by Universidade Federal de Pernambuco:
Common cold

Additional relevant MeSH terms:
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sodium Benzoate
Antifungal Agents
Anti-Infective Agents processed this record on September 21, 2017